Evaluación de la erupción maculopapular

Última revisão: 28 Sep 2025
Última atualização: 03 Jun 2025

Resumo

Diagnósticos diferenciais

comuns

  • Alergia a alimentos o a fármacos
  • Picaduras o mordeduras de insectos
  • Reacción adversa medicamentosa (p. ej., a un antibiótico, anticonvulsivo o alopurinol)
  • Quimioterapia
  • Infección por enterovirus y virus ECHO
  • Quinta enfermedad (eritema infeccioso)
  • Roséola (sexta enfermedad)
  • infección por virus de Epstein-Barr (VEB) (mononucleosis infecciosa)
  • Infección por citomegalovirus (CMV)
Detalhes completos

Incomuns

  • Reacción adversa no inmediata del medio de contraste yodado
  • Necrólisis epidérmica tóxica/síndrome de Stevens-Johnson
  • Reacción medicamentosa con eosinofilia y síntomas sistémicos
  • Eritema multiforme
  • exantema por seroconversión al VIH (también conocido como síndrome retroviral agudo)
  • Mpox
  • Sepsis
  • Infección por virus de la hepatitis B aguda
  • Infección por virus de la hepatitis C aguda
  • Rubéola (sarampión alemán)
  • Rubéola (sarampión)
  • Meningococemia
  • Escarlatina
  • Dermatitis exfoliativa estafilocócica
  • Síndrome de shock tóxico (exotoxina de Staphylococcus)
  • Fiebre maculosa de las Montañas Rocosas o fiebre maculosa mediterránea
  • Enfermedad aguda de injerto contra huésped
  • Enfermedad de Kawasaki (síndrome mucocutáneo linfonodular)
  • Enfermedad de Still de inicio en la juventud o en adultos
  • Sífilis (secundario)
  • Enfermedad del Ébola
  • Infección por el virus Zika
  • Infección por el virus de chikungunya
  • Dengue
Detalhes completos

Colaboradores

Autores

Adelaide A. Hebert, MD

Professor & Director of Pediatric Dermatology

Department of Dermatology and Pediatrics

UTHealth McGovern Medical School Houston

Houston

TX

Declarações

AAH has received research grants paid to UTHealth McGovern Medical School Houston from Pfizer, GlaxoSmithKline (GSK), Novan, Dermavant, Arcutis, and Verrica; has received honoraria from Pfizer, Verrica, and Novan; and is on data safety monitoring boards for GSK, Ortho Dermatologics, and Regeneron-Sanofi.

Yamila Goenaga, MD

Dermatology Resident

Department of Dermatology

University of Texas Health Sciences Center in Houston

Houston

TX

Declarações

YG declares that she has no competing interests.

Alexander J. Jafari, MD, MPH

Clinical Research Fellow

Department of Dermatology

UTHealth McGovern Medical School Houston

Houston

TX

Disclosures

AJJ declares that he has no competing interests.

Acknowledgements

Dr Adelaide A. Hebert, Dr Yamila Goenaga, and Dr. Alexander Jafari would like to gratefully acknowledge Dr Quoc-Bao Nguyen, Dr Mary DarConte, Dr Mark Naftanel, and Dr Hobart W. Walling, previous contributors to this topic.

利益声明

QN, MD, MN, and HWW declare that they have no competing interests.

同行评议者

Brian Swick, MD

Clinical Assistant Professor

University of Iowa College of Medicine

Iowa City

IA

利益声明

BS declares that he has no competing interests.

Kimberly Schulz, MD

Dermatologist

Town Square Dermatology

Coralville

IA

利益声明

KS declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Resuscitation Council UK. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. May 2021 [internet publication].全文

Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-73. 摘要

McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.全文  摘要

Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022 Dec;150(6):1333-93.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Evaluación de la erupción maculopapular images
  • 指南

    • Diagnostic testing for Ebola and Marburg virus diseases: interim guidance, 20 December 2024
    • Update on diagnosis and management of kawasaki disease: a scientific statement from the American Heart Association
    更多 指南
  • 患者教育信息

    Hepatitis B: ¿debo vacunarme?

    Hepatitis C: ¿qué tratamientos funcionan?

    更多 患者教育信息
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer